Literature DB >> 19342210

Antigen presentation by dendritic cells in vivo.

Elodie Segura1, José A Villadangos.   

Abstract

Dendritic cells (DC) are heterogenous, comprising several subpopulations of migratory and lymphoid-organ-resident types. Recent studies addressing the role of each subset in antigen presentation in vivo have revealed a complex division of labor within the DC network. In addition to CD8(+) DC, migratory lung or dermal DC can cross-present antigen in vivo. Migratory DC also transport to the lymph nodes antigens that can be transferred to resident DC for presentation. In inflammatory conditions, the antigen-presentation abilities of DC can be severely impaired, but an additional population of monocyte-derived DC then comes into play. Understanding the contribution of each DC subset to a physiological immune response is particularly relevant for rational vaccine design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342210     DOI: 10.1016/j.coi.2009.03.011

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  57 in total

1.  Characterization of mononuclear phagocytic cells in medaka fish transgenic for a cxcr3a:gfp reporter.

Authors:  Narges Aghaallaei; Baubak Bajoghli; Heinz Schwarz; Michael Schorpp; Thomas Boehm
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo.

Authors:  Aws Alshamsan; Samar Hamdy; Azita Haddadi; John Samuel; Ayman O S El-Kadi; Hasan Uludağ; Afsaneh Lavasanifar
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

3.  Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.

Authors:  Audrea M Burns; Anita S Chong
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

Review 4.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

5.  Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs.

Authors:  Alfred J Harvey; Scott A Kaestner; Diane E Sutter; Noel G Harvey; John A Mikszta; Ronald J Pettis
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

6.  Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease induction.

Authors:  Hongmei Li; Anthony J Demetris; Jennifer McNiff; Catherine Matte-Martone; Hung Sheng Tan; David M Rothstein; Fadi G Lakkis; Warren D Shlomchik
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

Review 7.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

Review 8.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

Review 9.  Endogenous and tumour-derived microRNAs regulate cross-presentation in dendritic cells and consequently cytotoxic T cell function.

Authors:  Siambi Kikete; Xiaoqian Chu; Li Wang; Yuhong Bian
Journal:  Cytotechnology       Date:  2016-05-18       Impact factor: 2.058

10.  Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.

Authors:  Annabell Bachem; Steffen Güttler; Evelyn Hartung; Frédéric Ebstein; Michael Schaefer; Astrid Tannert; Abdulgabar Salama; Kamran Movassaghi; Corinna Opitz; Hans W Mages; Volker Henn; Peter-Michael Kloetzel; Stephanie Gurka; Richard A Kroczek
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.